Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer

He will be responsible for the clinical strategy and development of Cristal Therapeutics’ nanomedicines

Cristal Therapeutics, a privately-held life sciences company developing novel nanomedicines against cancer and other diseases, by using its patented CriPec platform, has hired Edwin Klumper as Chief Medical Officer. He will be responsible for the clinical strategy and development of Cristal Therapeutics’ range of nanomedicines.

Before joining the firm, Klumper served as interim CEO of Dutch SMS-oncology, which he co-founded in 2007. He acted as CMO since the inception of the company until 2013.

Prior to SMS-oncology, he worked at Nabi Biopharmaceuticals as Vice-President Marketing & Sales Europe, at Amgen as Business Unit Director for the Netherlands, for the UK and as Brand Director Europe, at ASTA Medica as Product Manager, and at start-up Yew Tree Pharmaceuticals as Medical Director.

You may also like